Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.

ABSTRACT: The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation among cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profiling study designed to address this knowledge gap.

SUBMITTER: Au L 

PROVIDER: S-EPMC7470737 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature